Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.

Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich CA, Di Santo JP.

J Exp Med. 2010 Feb 15;207(2):273-80. doi: 10.1084/jem.20092029. Epub 2010 Feb 8.

2.

Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M.

Immunity. 2009 Aug 21;31(2):321-30. doi: 10.1016/j.immuni.2009.06.020. Epub 2009 Aug 13.

3.

Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

Colonna M.

Immunity. 2009 Jul 17;31(1):15-23. doi: 10.1016/j.immuni.2009.06.008. Review.

4.

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.

Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H.

Nat Immunol. 2009 Aug;10(8):864-71. doi: 10.1038/ni.1770. Epub 2009 Jul 5.

PMID:
19578368
5.

Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22.

Hughes T, Becknell B, McClory S, Briercheck E, Freud AG, Zhang X, Mao H, Nuovo G, Yu J, Caligiuri MA.

Blood. 2009 Apr 23;113(17):4008-10. doi: 10.1182/blood-2008-12-192443. Epub 2009 Feb 24.

6.

Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.

Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y.

Immunity. 2009 Jan 16;30(1):108-19. doi: 10.1016/j.immuni.2008.11.009.

7.

Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.

Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP.

Immunity. 2008 Dec 19;29(6):958-70. doi: 10.1016/j.immuni.2008.11.001. Epub 2008 Dec 11.

8.

Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells.

Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, Fibbe WE, Cornelissen JJ, Spits H.

Nat Immunol. 2009 Jan;10(1):66-74. doi: 10.1038/ni.1668. Epub 2008 Nov 23.

PMID:
19029905
9.

Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin.

Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D, Dalod M, Littman DR, Vivier E, Tomasello E.

Nat Immunol. 2009 Jan;10(1):75-82. doi: 10.1038/ni.1681. Epub 2008 Nov 23.

PMID:
19029904
10.

RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells.

Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, Diefenbach A.

Nat Immunol. 2009 Jan;10(1):83-91. doi: 10.1038/ni.1684. Epub 2008 Nov 23.

11.

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.

Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M.

Nature. 2009 Feb 5;457(7230):722-5. doi: 10.1038/nature07537. Epub 2008 Nov 2.

12.

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia.

Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK.

Nat Med. 2008 Mar;14(3):275-81. doi: 10.1038/nm1710. Epub 2008 Feb 10.

13.

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W.

Nat Med. 2008 Mar;14(3):282-9. doi: 10.1038/nm1720. Epub 2008 Feb 10.

PMID:
18264109
14.

Keeping NK cells in highly regulated antiviral warfare.

Lee SH, Miyagi T, Biron CA.

Trends Immunol. 2007 Jun;28(6):252-9. Epub 2007 Apr 27. Review.

PMID:
17466596
15.
16.

Evidence for discrete stages of human natural killer cell differentiation in vivo.

Freud AG, Yokohama A, Becknell B, Lee MT, Mao HC, Ferketich AK, Caligiuri MA.

J Exp Med. 2006 Apr 17;203(4):1033-43. Epub 2006 Apr 10.

17.

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.

Freud AG, Becknell B, Roychowdhury S, Mao HC, Ferketich AK, Nuovo GJ, Hughes TL, Marburger TB, Sung J, Baiocchi RA, Guimond M, Caligiuri MA.

Immunity. 2005 Mar;22(3):295-304.

18.

An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells.

Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR.

Nat Immunol. 2004 Jan;5(1):64-73. Epub 2003 Dec 21.

PMID:
14691482
19.

Organogenesis of lymphoid tissues.

Mebius RE.

Nat Rev Immunol. 2003 Apr;3(4):292-303. Review. Erratum in: Nat Rev Immunol. 2003 Jun;3(6):509.

PMID:
12669020
20.

IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes.

Xue HH, Kovanen PE, Pise-Masison CA, Berg M, Radovich MF, Brady JN, Leonard WJ.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13759-64. Epub 2002 Sep 27.

Items per page

Supplemental Content

Write to the Help Desk